Mangalam Drugs And Organics Ltd (MANGALAM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532637 | NSE: MANGALAM | Pharmaceuticals & Drugs | Small Cap

Mangalam Drugs&Org. Share Price

25.92 0.59 2.33%
as on 05-Dec'25 12:17

Mangalam Drugs And Organics Ltd (MANGALAM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532637 | NSE: MANGALAM | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Mangalam Drugs&Org.

Based on:

M-Cap below 100cr DeciZen not available

Mangalam Drugs And Organics stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
40.1 Cr.
52-wk low:
24.1
52-wk high:
129.9

Is Mangalam Drugs And Organics Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Mangalam Drugs&Org.: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Mangalam Drugs And Organics Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 29.1%30.2%25.4%1.8%10.7%28%18.3%6.7%1.2%8.4%-
Value Creation
Index
1.11.20.8-0.9-0.21.00.3-0.5-0.9-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 295303279228282385451372369318268
Sales YoY Gr.-2.7%-7.8%-18.5%24.1%36.3%17.3%-17.5%-1%-13.7%-
Adj EPS 11.214.512.3-5.15.217.712.40.8-5.74.3-12.3
YoY Gr.-29.3%-15.4%-141.6%NA240.5%-29.9%-93.5%-811.3%NA-
BVPS (₹) 36.954.265.660.465.782.695.19689.993.980.5
Adj Net
Profit
16.22319.4-8.18.22819.61.3-96.9-19
Cash Flow from Ops. 21.842.824.621.730.627.625.738.112.242.8-
Debt/CF from Ops. 2.71.52.82.91.62.33.127.82.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 0.9%2.4%-11%-13.7%
Adj EPS -10%-3.5%-29.5%NA
BVPS10.9%7.4%-0.4%4.4%
Share Price -24% -28.9% -42.9% -78.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
35.531.220.5-8.18.223.813.90.8-6.14.7-14.1
Op. Profit
Mgn %
12.815.516.84.38.415.110.96.94.711.44.3
Net Profit
Mgn %
5.57.67-3.62.97.34.30.3-2.52.2-7.3
Debt to
Equity
1.10.80.70.70.50.50.50.50.70.60.1
Working Cap
Days
130114130162136126131192201229131
Cash Conv.
Cycle
565862834748699570820

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Mangalam Drugs And Organics Ltd.

Standalone Consolidated
TTM EPS (₹) -12.3 -12.5
TTM Sales (₹ Cr.) 268 268
BVPS (₹.) 80.5 76.1
Reserves (₹ Cr.) 112 105
P/BV 0.31 0.33
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 24.08 / 129.90
All Time Low / High (₹) 3.43 / 441.50
Market Cap (₹ Cr.) 40.1
Equity (₹ Cr.) 15.8
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Mangalam Drugs&Org.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *20.0417.5218.0817.5814.8810.2611.0113.2313.2334.58
* Pledged shares as % of Promoter's holding (%)

Valuation of Mangalam Drugs&Org. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Mangalam Drugs&Org.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales295.02302.89279.38227.58282.35384.70451.07372.25368.59318.23
Operating Expenses 257.50256.97232.53217.90258.66326.68402.01346.53351.22282.43
Manufacturing Costs22.3823.0229.1526.6024.0130.1741.9945.3250.3055.25
Material Costs203.92195.94166.77153.61195.35251.96306.64250.44244.51167.37
Employee Cost 14.3919.0822.9825.8226.0429.8837.2534.6139.0740.59
Other Costs 16.8118.9313.6311.8713.2514.6716.1416.1517.3419.23
Operating Profit 37.5245.9246.859.6823.6958.0249.0525.7217.3835.80
Operating Profit Margin (%) 12.7%15.2%16.8%4.3%8.4%15.1%10.9%6.9%4.7%11.3%
Other Income 0.200.310.840.321.1800.090.440.120.50
Interest 9.2910.0411.788.6510.409.3311.1612.9613.9214.93
Depreciation 4.415.016.577.098.229.1810.2510.9914.6316.38
Exceptional Items 0000000000
Profit Before Tax 24.0231.1829.35-5.746.2539.5227.732.21-11.064.99
Tax 7.988.919.462.29-211.558.080.94-2.01-1.93
Profit After Tax 16.0322.2819.89-8.038.2527.9719.661.27-9.056.92
PAT Margin (%) 5.4%7.4%7.1%-3.5%2.9%7.3%4.4%0.3%-2.5%2.2%
Adjusted EPS (₹)11.214.112.6-5.15.217.712.40.8-5.74.4
Dividend Payout Ratio (%)0%0%4%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 53.0485.72103.7795.66103.94130.79150.56151.96142.35148.66
Share Capital 14.3815.8315.8315.8315.8315.8315.8315.8315.8315.83
Reserves 38.6669.8987.9479.8388.11114.96134.73136.13126.52132.83
Minority Interest0000000000
Debt52.3058.1761.9059.1146.0358.0672.2068.3387.9581.17
Long Term Debt16.9216.8511.158.604.176.8825.1018.7713.359.23
Short Term Debt35.3841.3250.7550.5141.8651.1847.1049.5774.6071.94
Trade Payables20.6820.7837.6332.4156.5943.3954.5595.4383.0591.32
Others Liabilities 33.7524.8423.5024.1724.1031.8751.1242.2743.7938.10
Total Liabilities 159.76189.50226.79211.36230.67264.11328.43357.98357.14359.24

Fixed Assets

Gross Block97.57140.26156.14165.15170.92196.70223.81241.40260.69280.14
Accumulated Depreciation43.3847.7054.2361.6669.8578.8888.8599.04113.38124.62
Net Fixed Assets 54.1992.56101.91103.49101.07117.82134.96142.36147.31155.52
CWIP 4.9300.070.201.246.355.719.497.742.69
Investments 0.241.640.240.240.220.22000.030.03
Inventories47.3437.2560.1373.4564.8458.59117.11137.47123.64138.80
Trade Receivables30.1436.8245.2117.6339.9854.3146.4946.5327.9439.07
Cash Equivalents 0.500.630.431.431.630.591.951.041.012.57
Others Assets 22.4320.6118.7914.9121.6826.2222.2021.0949.4820.54
Total Assets 159.76189.50226.79211.36230.67264.11328.43357.98357.14359.24

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 21.8142.8024.5821.6930.5527.5525.7138.0812.1742.76
PBT 24.0231.1829.35-5.746.2539.5227.732.21-11.064.99
Adjustment 13.8517.4518.3016.2218.7117.2422.3724.1227.8130.37
Changes in Working Capital -12.111.5-16.8111.215.64-19.94-15.5911.72-4.397.49
Tax Paid -3.95-7.33-6.260-0.05-9.27-8.810.03-0.19-0.08
Cash Flow From Investing Activity -10.88-39.45-15.95-9.26-6.87-31.29-27.33-22.17-17.91-19.47
Capex -10.91-39.46-15.98-9.28-6.89-31.29-27.53-22.17-17.88-19.47
Net Investments 0-00.0100.0200.210-0.030
Others 0.020.020.020.02000000
Cash Flow From Financing Activity -11.11-3.22-8.82-11.43-23.482.702.98-16.825.70-21.71
Net Proceeds from Shares 00.9400000000
Net Proceeds from Borrowing -21.65-0.07-5.70-2.55-4.422.7018.23-6.34-5.41-4.12
Interest Paid -9.29-10.04-11.76-8.65-10.40-9.33-11.16-12.96-13.92-14.93
Dividend Paid 00-0.790000000
Others 19.835.949.43-0.24-8.659.32-4.092.4725.03-2.66
Net Cash Flow -0.180.13-0.2010.20-1.041.36-0.91-0.041.57

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)38.9132.1120.99-8.058.2723.8313.970.84-6.154.76
ROCE (%)29.1430.1825.351.7610.6628.0118.346.651.238.4
Asset Turnover Ratio1.841.791.481.181.421.561.521.081.030.89
PAT to CFO Conversion(x)1.361.921.24N/A3.70.981.3129.98N/A6.18
Working Capital Days
Receivable Days45394944344541463738
Inventory Days63495894815971125129151
Payable Days68396483837258109133190

Mangalam Drugs And Organics Ltd Stock News

Mangalam Drugs And Organics Ltd FAQs

The current trading price of Mangalam Drugs&Org. on 05-Dec-2025 12:17 is ₹25.92.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Mangalam Drugs&Org. stood at ₹40.09.
The latest P/E ratio of Mangalam Drugs&Org. as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Mangalam Drugs&Org. as of 04-Dec-2025 is 0.31.
The 52-week high of Mangalam Drugs&Org. is ₹129.9 and the 52-week low is ₹24.08.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Mangalam Drugs&Org. is ₹267.8 ( Cr.) .

About Mangalam Drugs And Organics Ltd

Mangalam Drugs & Organics Limited (Mangalam) is a part of the MangalamGroup promoted by Dhoot family in 1972 as Advent Pharma PrivateLimited with a view to set up a plant for manufacture of organic andinorganic chemicals. Mangalam Drugs & Organics commmenced its business in 1977.

The company manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.

The Company has a diversified product range having synergies in operations and substantial economies of scale. It is amongst the top three manufacturers in India in almost all the products that it manufactures.

Today Mangalam Drugs & Organics enjoys a very strong brand name in the domestic market. It has over two decades of experience in the industry with a very wide and satisfied customer base.

The company has a state of art multi-product manufacturing facilitiesat Vapi in Gujarat and Sangamner in Maharashtra for production of bulkdrugs perfumery chemicals inorganic chemicals and disperse dyesintermediaries with a strong in-house Research and Development base.

Product range of the company includes:

Active Pharma Ingredients (API)

  • Anti Malarial
  • Analgesic / Anti Inflammatory
  • Diuretic
  • Anti Hypertensive
  • Anti Convulsant

API Under Development

  • Intermediates
  • Antiurolithic

Prefumery / Specialty Chemicals

  • Phenyl Ethyl Alcohol
  • Phenyl Ethyl Methyl Ether
  • Phenyl Ethyl Acetate

Disperse Dye Intermediates

  • Meta Nitro Aniline (Mna)(99-09-2)
  • Meta Amino Propionilide (MAP)
  • Meta Amino Acetanilide (MAA) (162-28-3)
  • Para Amino Acetanilide (PAA) 122-80-5)
  • Para Amino Propionilide (PAP) (59690-89-0)
  • N-Cyano Ethyl Aniline (1075-76-9)
  • N,N-BIS (2-Hydroxy Ethyl) Meta Chloro Aniline (Mangalam-1) (92-00-2)
  • N,N-BIS (2-Acetoxy Ethyl) Meta Chloro Aniline (Mangalam -1A) (26692-46-6) etc.

Achievements/ recognition:

  • Awarded the ISO 9001:2000 Management System Certificate from DNV for Design Development, Manufacture and supply of Bulk Drugs, and Dyes Intermediates.
  • Received the WHO GMP Certificate for its Bulk Drug manufacturing Plant
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×